Middle EAST Pharmacogenomics Market Intelligence Study: Current...

added blog Other

2026-03-02 10:35:55 -

Middle EAST Pharmacogenomics Market Intelligence Study: Current Scenario and Future Potential

The Middle EAST Pharmacogenomics Market was valued at USD 1.2 billion in 2024 and is projected to reach USD 3.5 billion by 2034, registering a CAGR of 11.5%. This growth trajectory is underpinned by several factors, including the increasing prevalence of genetic disorders, advancements in genomic technologies, and a growing emphasis on personalized medicine. As healthcare systems in the region...

0 Comments 0 Shares 514 Views 0 Reviews